Advancing therapeutic development through research and development of innovative assay (test) designs and chemical library screening methods. Learn more.
-
Research
-
- Funding & Notices
-
Assay Development and Screening Technology (ADST)
NCATS Researchers Design an Innovative Approach to Speed Search for Rare Disease Therapies
NCATS researchers lead a collaborative team to design an innovative coincidence-reporter approach to find potential treatments for Charcot-Marie-Tooth disease (CMT), one of the most common inherited neurological diseases.
About ADSTFind out more about the ADST program, its goals, and its progress to date.
Scientific CapabilitiesAccess state-of-the-art expertise, tools and technologies for assay development and high-throughput screening.
Work with ADSTLearn how to collaborate with the ADST program to develop an assay or screen.
Find out more about the ADST program, its goals, and its progress to date.
Access state-of-the-art expertise, tools and technologies for assay development and high-throughput screening.
Learn how to collaborate with the ADST program to develop an assay or screen.
Work with Us
Find out more and contact Manju Swaroop to get started.
ADST in Action
A collaboration involving a patient advocacy group, pharmaceutical companies, academic researchers and ADST program experts culminated in an innovative advance in drug discovery technology, enabling the team to identify a potential new drug target for one of the most common forms of an inherited neurological disorder called Charcot-Marie-Tooth disease. See more ADST in action.
NCATS Programs & Initiatives
- Funding & Notices
-
